The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Validating RNAseq-signatures of vorinostat (VOR) sensitivity and resistance in patients with newly diagnosed glioblastoma (GBM) treated with VOR, temozolomide and radiation therapy in Alliance N0874/ABTC-0902.
 
S. Keith Anderson
Patents, Royalties, Other Intellectual Property - Genome DX Biosciences, Inc.
 
C. Ryan Miller
No Relationships to Disclose
 
Jann Nagina Sarkaria
Research Funding - Basilea; BeiGene; Genentech; GlaxoSmithKline; Glionova; Lilly; Novartis; Peloton Therapeutics; Sanofi
 
Kurt A. Jaeckle
Consulting or Advisory Role - Bristol-Myers Squibb; Orbus Therapeutics
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Orbus Therapeutics
 
Jan C. Buckner
Travel, Accommodations, Expenses - Genentech/Roche; Genentech/Roche
 
Keith L. Ligon
Consulting or Advisory Role - Midatech Pharma
Research Funding - Plexxikon
Patents, Royalties, Other Intellectual Property - Molecular Diagnostics Assay Patent
 
Karla V. Ballman
Consulting or Advisory Role - ARIAD; Astellas Pharma; Hospira
Patents, Royalties, Other Intellectual Property - Immune enrichment signature for response to trastuzumab in HER2+ breast cancer (Inst); Prostate cancer signature patent (Inst)
 
Dennis Frederic Moore
No Relationships to Disclose
 
David Schiff
Honoraria - Genentech; Heron; Midatech Pharma; Oxigene
Consulting or Advisory Role - Genentech; Heron; Midatech Pharma; Oxigene
Research Funding - Angiochem; Celldex; Cortice Biosciences (Inst); ImmunoCellular Therapeutics; Novocure (Inst); Stemline Therapeutics; VBL Therapeutics
Travel, Accommodations, Expenses - Merck
 
Manmeet Singh Ahluwalia
Honoraria - Elekta
Consulting or Advisory Role - Caris Life Sciences; Incyte; Monteris Medical; MRI solutions ; Novocure
Research Funding - Boehringer Ingelheim; Lilly/ImClone; Novartis; Novocure; Spectrum Pharmaceuticals; TRACON Pharma
 
Eudocia Quant Lee
Consulting or Advisory Role - Genentech
 
Laura E. Horvath
No Relationships to Disclose
 
Elizabeth Robins Gerstner
No Relationships to Disclose
 
Glenn Jay Lesser
Honoraria - Abbvie; Insys Therapeutics; Novocure; Stemline Therapeutics
Research Funding - Celldex; ImmunoCellular Therapeutics; Novartis
 
Michael Prados
Honoraria - Actelion
Consulting or Advisory Role - Actelion
Research Funding - Genentech/Roche (Inst); Nativis (Inst); Novartis (Inst)
 
Stuart A. Grossman
Stock and Other Ownership Interests - Axxia Pharmaceuticals
Honoraria - MedImmune; Roche/Genentech
Consulting or Advisory Role - Midatech Pharma
Research Funding - Erimos Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Patent related to a subcutaneous polymeric opioid delivery system have been awarded.
 
Caterina Giannini
No Relationships to Disclose
 
Patrick Y. Wen
Speakers' Bureau - Merck
Research Funding - Merck
 
Evanthia Galanis
No Relationships to Disclose